Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Hangzhou Guichuang Biopharmaceutical Co., Ltd., established on 2012-11-14, Business scope includes technical development of biomedical raw materials and preparations,technical consulting,Technology Transfer and Technical Services.

SciPharm SARL focuses on developing pharmaceutical treatments against orphan diseases. It is also engaged in the development and distribution of precision ambulatory infusion pumps and a platform that connects medical devices to the cloud, which enables remote monitoring as well as distant programming of the devices. The company was founded in 2010 and is headquartered in Mertert, Luxembourg.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

IMTM GmbH is engaged in the development of therapeutic drugs for the treatment of immune dysfunction diseases and conditions. The firm specializes in silico, in vitro, and in vivo methods that focus on the discovery, optimization, and analysis of drug candidates. Its service areas encompass drug design, pharmaceutical development, experimental medicine research, clinical trials, and laboratory testing. The company was founded in 1996 and is headquartered in Magdeburg, Germany.

Shanghai Dishuo Beken Medical Laboratory Co., Ltd., established on 2015-09-21, Business scope includes engaging in technical services in the field of biotechnology,technical consulting,technology transfer,technology development,for-profit medical institution,Laboratory equipment and consumables,laboratory reagent,computer,Sales of software, hardware and auxiliary equipment,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenzhen Dishuo Beken Precision Medicine Co., Ltd., established on 2016-07-14, Business scope includes general business items:Engaged in technology development in the field of life science and biotechnology,technical consulting,Instrumentation,laboratory equipment(except medical devices),chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),computer,Software and Auxiliary Equipment(In addition to special products for computer information system security)Sales,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments],The licensing program is:

Shanghai Dishuo Beken Biotechnology Co., Ltd., established on 2011-11-07, The scope of business includes engaging in technology development in the field of biotechnology,technical consulting,Instrumentation,laboratory equipment(except medical devices),chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),computer,Software and Auxiliary Equipment(In addition to special products for computer information system security)Sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Dishuo Beken Gene Technology Co., Ltd., established on 2018-08-10, The scope of business includes engaging in technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Biological reagents for non-clinical diagnosis,Instrumentation,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),computer,Sales of software, hardware and auxiliary equipment,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the “BiFAR” technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.